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Innate lymphoid cells (ILCs) regulate the epithelial barrier function and immunity in the gut. How ILC numbers
are maintained is unknown. In this issue of Immunity, Qiu et al. (2012) report that the transcription factor aryl
hydrocarbon receptor controls survival and function of gut-residing ILCs.The aryl hydrocarbon receptor (Ahr) is a
ligand-dependent basic helix-loop-helix
transcription factor that resides in the
cytoplasm of many cell types in complex
with several proteins including heat
shock protein (Hsp) 90. The prototypic
Ahr ligand is the stable toxin 2, 3, 7, 8-
tetrachlorodibenzo-p-dioxin (TCDD). En-
dogenous ligands include the tryptophan
photoproduct 6-formylindolo-[3,2-b]-car-
bazole (FICZ). Also dietary ligands, such
as those contained in vegetables of the
family Brassicaceae, including broccoli,
can bind Ahr (Li et al., 2011). These
ligands enter the cells in a poorly charac-
terized manner and after binding to Ahr,
the complex translocates to the nucleus
where Ahr associates with the Ahr nuclear
transporter, Arnt. The Ahr-Arnt complex is
then able to induce transcription of an
array of target genes (reviewed in Veld-
hoen and Duarte, 2010). It was previously
found that Ahr is involved in differentia-
tion and function of T helper-17 (Th17)
cells and regulatory T (Treg) cells (Veld-hoen and Duarte, 2010). Interestingly,
Ahr is a key factor for production of inter-
leukin-22 (IL-22) by mouse Th17 cells
(Veldhoen et al., 2008) and human Th22
cells (Trifari et al., 2009). IL-22 regulates
immunity and tissue homeostasis at
barrier surfaces including the gut (Son-
nenberg et al., 2011). Recent work
demonstrates that innate lymphoid cells
(ILCs), which are dependent on the tran-
scription factor Rorgt, constitute a major
source of IL-22 (Spits and Di Santo,
2011). Rorgt+ ILCs, which includes
lymphoid tissue inducer (LTi) cells and
ILC22 (also called NK22 cells) are
members of a larger family of related
ILCs that include, in addition to Rorgt+
ILCs, conventional natural killer (NK) cells
and type 2 ILCs, with the latter dedicated
to the production of Th2 cytokines IL-5
and IL-13 (Spits and Di Santo, 2011). LTi
cells mediate lymph node formation
during embryonic development and after
birth these cells, perhaps in conjunction
with ILC22, are involved in formation ofcryptopatches (CP) and isolated lymphoid
follicles (ILFs) in the gut.
Three recent papers, including one in
the current issue of Immunity (Qiu et al.,
2012; Kiss et al., 2011; Lee et al., 2011),
identify Ahr as an important regulator of
homeostasis and IL-22 production by
Rorgt+ ILCs in the gut. Qiu et al. (2012)
has shown that Ahr deficiency caused
a marked decrease in the frequency of
LTi cells and ILC22 in the gut. The reduc-
tion of Rorgt+ ILCs was also seen in bone
marrow chimeras with mice receiving
Ahr/ stem cells as well as in Ahr/
Rag1/ mice that lack T cells indicating
that the effects of Ahr deficiency on
Rorgt+ ILC are cell intrinsic. This notion
was further supported by the observation
that specific deletion of Ahr in Rorgt-
expressing cells (including ILCs) has the
same consequences for Rorgt+ ILCs as
genetic ablation of Ahr in all mouse cells
(Lee et al., 2011).
The reduction of gut Rorgt+ ILC
numbers in Ahr-deficient mice occurred36, January 27, 2012 ª2012 Elsevier Inc. 5
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Figure 1. Ahr Regulates Survival and IL-22 Production by Rorgt+ ILCs
Ahr ligands derived from dietary products or endogenous ligands bind to Ahr. This results in its trans-
location to the nucleus where Ahr forms a complex with Arnt. This complex serves to induce expression
of Bcl-2, cKit, Il-7R, and Notch2, which together promote survival of the ILC. Ahr is also required for ILCs
to support formation of ILFs, thus providing an environment for IgA-producing B cells. In addition,
after activation via the IL-23R, Ahr together with Rorgt regulate expression of IL-22. IL-22 engages
the IL-22R expressed on cells in the epithelial layer to induce production of antimicrobial peptides and
proteins like RegIIIg that contribute to protection against pathogenic bacteria such as C. Rodentium.
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in the first 3weeks after birth, the numbers
of Rorgt+ ILCs in Ahr-deficient and Ahr-
sufficient animals were comparable. As
a consequence, the formation of Peyer’s
patches that occurred during fetal devel-
opment was not affected by AhR defi-
ciency, whereas formation of isolated
lymphoid structures, which was mediated
by Rorgt+ ILCs after birth, was strongly
reduced in Ahr-deficient animals. ILFs
are formed by a crosstalk between Rorgt+
ILCs, in particular LTi cells, stromal cells,
dendritic cells, and B cells which mostly
produce IgA specific for bacterial prod-
ucts (Figure 1; Tsuji et al., 2008). Rorgt+
ILCs mediate tissue immune reactions
early after infection with C. rodentium in
mice by inducing gut epithelial cell to
secrete antimicrobial peptides such as
b-defensins and proteins like RegIIIg. IL-
22 production by ILCs in this setting is
critically regulated by IL-23, produced by
activated macrophages and dendritic
cells. IL-23 responsiveness and IL-23
receptor expression was reduced in ILCs
of Ahr-deficient mice and not unexpect-
edly, these mice succumbed to
C. rodentium infection. Hydrodynamic
injection of an IL-22-expressing plasmid
restored protection against this pathogen,
which proved that the effect of Ahr defi-
ciency on the immune reactivity against6 Immunity 36, January 27, 2012 ª2012 ElsevC rodentium is mediated by a loss of IL-
23-regulated IL-22 production.
A few questions arise from these find-
ings: (1) Which Ahr ligands are important
for regulating Rorgt+ ILCs? (2) How does
Ahr affect homeostasis of Rorgt+ ILCs?
(3) What is the mechanism of regulating
IL-22 production by Ahr? After the ob-
servation that the sharp drop in Rorgt+
ILCs was observed only after weaning,
Qiu et al. (2012) explored the idea that
colonizing microbiota may provide Ahr
ligands. Applying a mix of strong antibi-
otics to adult mice, however, did not
affect the reduction of ILC numbers in
the gut in Ahr/ mice as compared to
Ahr+/+ mice. In addition, sequencing of
RNA associated with the 16S subunit of
the prokaryotic ribosome did not reveal
a difference in the composition of the
microbiota in Ahr/ and Ahr+/+ mice.
Also, maintenance of mice under germ-
free conditions did not affect develop-
ment and homeostasis of Rorgt+ ILCs
(Kiss et al., 2011; Lee et al., 2011). Thus,
it is unlikely that the microbiota constitute
an important regulator of Rorgt+ ILCs.
Meanwhile, two groups have explored
the possibility that dietary products are
responsible for maintaining the homeo-
stasis of gut residing ILCs. Using defined
diets, Kiss et al. (2011) observed that
mice fed with a diet free of Ahr-bindingier Inc.phytochemicals display the same Rorgt+
ILC deficiency as Ahr/ mice and as
a consequence lack CPs and ILFs.
Addition of the known dietary Ahr ligand
indole-3-carbinol, a hydrolytic product
of the glucosinolate glucobrassicin,
which is contained in the plants of the
Brassicaceae family (e.g., broccoli),
restores the Rorgt+ ILC defect (Kiss
et al., 2011). These findings are similar to
those of Veldhoen and collaborators
who recently showed that homeostasis
of intraepithelial T cells (IEL) is affected
by dietary products interacting with Ahr
(Li et al., 2011). Another study, however,
failed to demonstrate an effect of dietary
products on homeostasis and function of
Rorgt+ ILCs and these authors speculated
that endogenous Ahr ligands such as the
tryptophane catabolite kynurenine drive
survival and function of ILC22 (Lee
et al., 2011). Further experiments should
resolve these discrepancies.
With regard to the question on how Ahr
ligation affects Rorgt+ ILC homeostasis,
Qiu et al. (2012) observed that the Rorgt+
cells in Ahr/mice were more apoptotic,
and this may be due to the lower expres-
sion of the antiapoptotic protein Bcl-2.
Also expression of IL-7 receptor (IL-7R)
was decreased by Ahr ablation and the
authors speculated that the reduction of
IL-7R diminished IL-7-induced Bcl-2
expression resulting in decreased ILC
survival. Kiss et al. (2011), however, did
not observe a reduction of IL-7R on
Ahr/ ILC, but instead observed a sharp
decrease in expression of cKit, the
receptor for stem cell factor. The idea
that cKit is important for Ahr-mediated
regulation of the Rorgt+ ILC pool size is
supported by the finding that KitWv/Wv
mice, which express a cKit variant with
impaired kinase activity, have reduced
numbers of Rorgt+ ILCs and decreased
numbers and sizes of CPs and ILFs.
Interestingly, Ahr might regulate ILC22
via Notch signaling. In a micro array anal-
ysis, Lee et al. (2011) found a higher
expression of Notch1 and its downsteam
target HES1 in Ahr-sufficient than in Ahr-
deficient ILCs. Fitting with this notion,
Rorgt+ ILCs are reduced in mice deficient
for RBP-Jk, a factor which associates
with all Notch isoforms to drive transcrip-
tion of target genes. However, the RBP-Jk
deficiency was not a complete pheno-
copy of Ahr deficiency. Nonetheless,
these findings suggest that Notch
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Ahr in controlling the numbers of Rorgt+
ILCs; however, experiments in which
Notch1 or Notch2 are specifically deleted
in Rorgt+ ILCs are needed to verify this
point.
As indicated above, Ahr also affects
production of IL-22. Investigating the
underlying mechanism, Qiu et al. (2012)
found that the Il22 locus contained
multiple Ahr-responsive elements that
were clustered with Ror-responsive ele-
ments. Further analysis by chromatin
immunoprecipitation provided evidence
that both Rorgt and Ahr bind directly
to their response elements in the Il22
locus. Recruitment of Ahr to the Il22
locus but not to the locus of another Ahr
target, Cyp1a1, was strongly enhanced
by Rorgt. The corecruitment of Ahr and
Rorgt to the Il22 locus explains why
these factors synergistically enhance IL-
22 expression.In conclusion, Ahr is emerging as a
sentinel that guarantees optimal survival
and function of innate and adaptive
immune cells in the gut. This sentinel
needs to be fed continuously by endoge-
nous ligands and ligands derived from
dietary products. Ahr may be an inter-
esting target for therapeutic intervention
in inflammatory bowel diseases. This re-
quires knowledge of how Ahr affects the
function of IEL and Rorgt+ ILCs in the
human gut. In addition, future research
should be aimed at elucidating the relative
importance of dietary and endogenous
Ahr ligands in regulating immunity.
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Type I interferon is a family of antiviral cytokines linked to human autoimmune diseases. In this issue of
Immunity, Gall et al. (2012) characterize, in a murine model of autoimmunity, the origin and progression of
the type I interferon response leading to disease.Detection of nucleic acids and induction of
type I interferons (IFNs) are fundamental
steps in antiviral defense. Type I IFN
production is normally transient, and
chronic activation of this pathway by
host-derived DNA and RNA has been
associated with the development of auto-
immune diseases, such as systemic lupus
erythematosus (SLE), dermatomyositis
(DM), and type 1 diabetes (Banchereau
and Pascual, 2006). Negative regulation
of type I IFN production must therefore
be in place to prevent unwanted inflam-
mation (Richards and Macdonald, 2011).
Increased IFN production has also re-cently been recognized as a central path-
ogenic event in a group of rare Mendelian
disorders including Aicardi-Goutieres
syndrome (AGS), a severe inflammatory
disorder affecting primarily the brain and
skin, that mimics congenital viral infec-
tions and may share overlapping features
with SLE (Crow, 2011). In this issue of
Immunity, Gall et al. (2012) characterize
the origin and progression of the type I
interferon response and the downstream
mechanisms leading to autoimmune
disease in a murine model of AGS.
Both extracellular and intracellular
nucleic acids can trigger IFN productionby binding to endosomal and cytosolic
sensors, respectively. Extracellular nu-
cleic acids are recognized by endosomal
Toll-like receptor 3 (TLR3), TLR7, and
TLR9, which are expressed on antigen-
presenting cells and a few other cell
types. Although type I IFNs can be
produced in small quantities by virtually
every cell, the specialized plasmacytoid
dendritic cells (pDCs) stand out for their
ability to swiftly produce large amounts
of these cytokines upon TLR triggering.
Cytosolic nucleic acids are sensed by
ubiquitously expressed, cell-intrinsic re-
ceptors that trigger Type I IFN responses36, January 27, 2012 ª2012 Elsevier Inc. 7
